title: Dexamethasone implants and neovascular glaucoma in central retinal vein occlusion.
authors.forename: Lavnish
authors.initials: L
authors.lastname: Joshi
authors.forename: Oren
authors.initials: O
authors.lastname: Tomkins-Netzer
authors.forename: Victor
authors.initials: V
authors.lastname: Menezo
authors.forename: Ahmed
authors.initials: A
authors.lastname: Sallam
authors.forename: Nigel
authors.initials: N
authors.lastname: Kirkpatrick
authors.forename: Sue
authors.initials: S
authors.lastname: Lightman
authors.forename: Simon R J
authors.initials: SR
authors.lastname: Taylor
mesh_terms: D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects*; D004343:Drug Implants; D005451:Fluorescein Angiography; D015355:Glaucoma, Neovascular / Q000139:chemically induced* / Q000175:diagnosis; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects*; D006068:Gonioscopy; D006801:Humans; D007429:Intraocular Pressure; D007498:Iris / Q000098:blood supply / Q000473:pathology; D008297:Male; D009389:Neovascularization, Pathologic / Q000139:chemically induced / Q000175:diagnosis; D012170:Retinal Vein Occlusion / Q000188:drug therapy*; D012189:Retrospective Studies; D014792:Visual Acuity / Q000502:physiology; D014822:Vitreous Body / Q000187:drug effects
chemical_list: D004343:Drug Implants; D005938:Glucocorticoids; D003907:Dexamethasone